Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Arkadi A Chines"'
Autor:
Paul D Miller, Jonathan D Adachi, Ben‐Hur Albergaria, Angela M Cheung, Arkadi A Chines, Evelien Gielen, Bente L Langdahl, Akimitsu Miyauchi, Mary Oates, Ian R Reid, Norma Ruiz Santiago, Mark Vanderkelen, Zhenxun Wang, Zhigang Yu
Publikováno v:
Miller, P D, Adachi, J D, Albergaria, B H, Cheung, A M, Chines, A A, Gielen, E, Langdahl, B L, Miyauchi, A, Oates, M, Reid, I R, Santiago, N R, Vanderkelen, M, Wang, Z & Yu, Z 2022, ' Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease ', Journal of Bone and Mineral Research, vol. 37, no. 8, pp. 1437-1445 . https://doi.org/10.1002/jbmr.4563
Patients with osteoporosis and chronic kidney disease (CKD) are at increased risk of fracture and associated negative outcomes, including increased mortality. The present post hoc analysis of two randomized, multicenter, phase 3 clinical trials-Fract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::275b6557dc439138ab47615df0fb7c5c
https://pure.au.dk/portal/da/publications/efficacy-and-safety-of-romosozumab-among-postmenopausal-women-with-osteoporosis-and-mildtomoderate-chronic-kidney-disease(6e1159b5-a9aa-415a-afe4-1b1285f1835b).html
https://pure.au.dk/portal/da/publications/efficacy-and-safety-of-romosozumab-among-postmenopausal-women-with-osteoporosis-and-mildtomoderate-chronic-kidney-disease(6e1159b5-a9aa-415a-afe4-1b1285f1835b).html
Autor:
Santiago, Palacios, Stuart L, Silverman, Tobie J, de Villiers, Amy B, Levine, Stefan, Goemaere, Jacques P, Brown, Fiorenzo, De Cicco Nardone, Robert, Williams, Teresa L, Hines, Sebastian, Mirkin, Arkadi A, Chines, M, Henderson
Publikováno v:
Menopause. 22:806-813
In a 3-year randomized, double-blind, osteoporosis treatment study (N = 7,492), bazedoxifene 20 mg and bazedoxifene 40 mg significantly (P0.05) reduced the risk of new vertebral fractures by 42% and 37%, respectively, compared with placebo in postmen
Autor:
Jonathan D. Adachi, William G. Bensen, Jacques Brown, David Hanley, Anthony Hodsman, Robert Josse, David L. Kendler, Brian Lentle, Wojciech Olszynski, Louis-George Ste.-Marie, Alan Tenenhouse, Arkadi A. Chines, Algis Jovaisas, William C. Sturtridge, Tassos P. Anastassiades, John G. Hanly, Janet E. Pope, Reginald Dias, Zebulun D. Horowitz, Simon Pack
Publikováno v:
New England Journal of Medicine. 337:382-388
Osteoporosis is a recognized complication of corticosteroid therapy. Whether it can be prevented is not known. We conducted a 12-month, randomized, placebo-controlled study of intermittent etidronate (400 mg per day for 14 days) followed by calcium (
Publikováno v:
Clinical pharmacology in drug development. 3(4)
Bazedoxifene is a novel selective estrogen receptor modulator in clinical development for the prevention and treatment of postmenopausal osteoporosis. This phase 1, double-blind, randomized, placebo-controlled study (N = 107) of healthy postmenopausa
Autor:
Geusens P; Department of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium., Bevers MS; Department of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands.; NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands., van Rietbergen B; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.; Department of Orthopedic Surgery, Maastricht University Medical Center, Maastricht, The Netherlands., Messina OD; IRO Medical Center, Investigaciones Reumatologicas y Osteologicas SRL, Buenos Aires, Argentina., Lespessailles E; Regional Hospital of Orleans, Translational Medicine Research Platform, PRIMMO, Orleans, France., Oliveri B; INIGEM, Hospital de Clínicas José de San Martin, Buenos Aires, Argentina., Chapurlat R; INSERM UMR 1033, Université de Lyon, Hospital Edouard Herriot, Lyon, France., Engelke K; Bioclinica Inc, Hamburg, Germany.; Department of Medicine 3, FAU University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany., Chines A; Amgen Inc, Thousand Oaks, CA, USA., Huang S; Amgen Inc, Thousand Oaks, CA, USA., Saag KG; University of Alabama at Birmingham, Birmingham, AL, USA., van den Bergh JP; Department of Internal Medicine, Subdivision of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.; Department of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands.; NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jun; Vol. 37 (6), pp. 1136-1146. Date of Electronic Publication: 2022 Apr 19.
Autor:
Farlay D; INSERM, UMR 1033, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France., Rizzo S; INSERM, UMR 1033, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France., Dempster DW; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.; Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY, USA., Huang S; Clinical Development, Amgen Inc., Thousand Oaks, CA, USA., Chines A; Clinical Development, Amgen Inc., Thousand Oaks, CA, USA., Brown JP; CHU de Quebec Research Centre, Laval University, Quebec City, Canada., Boivin G; INSERM, UMR 1033, University of Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 May; Vol. 37 (5), pp. 856-864. Date of Electronic Publication: 2022 Mar 24.
Autor:
Eastell R; Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK., Vittinghoff E; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Lui LY; California Pacific Medical Center, San Francisco, CA, USA., McCulloch CE; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Pavo I; Eli Lilly and Company, Lilly Research Centre, Windlesham, UK., Chines A; Amgen Inc., Thousand Oaks, CA, USA., Khosla S; Mayo Clinic College of Medicine, Rochester, MN, USA., Cauley JA; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA., Mitlak B; Radius Health, Boston, MA, USA., Bauer DC; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Bouxsein M; Center for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA., Black DM; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2022 Jan; Vol. 37 (1), pp. 29-35. Date of Electronic Publication: 2021 Sep 24.
Autor:
Hu YJ; Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY, USA., Chines A; Amgen Inc., Thousand Oaks, CA, USA., Shi Y; Amgen Inc., Thousand Oaks, CA, USA., Seeman E; Departments of Endocrinology and Medicine, Austin Health, University of Melbourne, Melbourne, Australia; Mary MacKillop Institute of Healthy Aging, Australian Catholic University, Melbourne, Australia., Guo XE; Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY, USA. Electronic address: ed.guo@columbia.edu.
Publikováno v:
Bone [Bone] 2022 Jan; Vol. 154, pp. 116187. Date of Electronic Publication: 2021 Sep 14.
Autor:
Brown JP; Centre Hospitalier Universitaire (CHU) de Québec Research Centre, Department of Medicine, Rheumatology Division, Laval University, Quebec City, Québec, Canada., Engelke K; Bioclinica, Hamburg, Germany.; Department of Medicine 3, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany., Keaveny TM; Departments of Mechanical Engineering and Bioengineering, University of California Berkeley, Berkeley, California, USA., Chines A; Amgen Inc., Thousand Oaks, California, USA., Chapurlat R; Institut National de la Santé et de la Recherche Médicale (INSERM) Unités Mixtes de Recherche (UMR) 1033, Université de Lyon, Hôpital E Herriot, Lyon, France., Foldes AJ; Osteoporosis Center, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Nogues X; Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES), Autonomous University of Barcelona, Barcelona, Spain., Civitelli R; Musculoskeletal Research Center, Washington University School of Medicine, St. Louis, Missouri, USA., De Villiers T; Department of Obstetrics and Gynaecology, Stellenbosch University, Stellenbosch, South Africa., Massari F; Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires, Argentina., Zerbini CAF; Centro Paulista de Investigação Clinica, São Paulo, Brazil., Wang Z; Amgen Inc., Thousand Oaks, California, USA., Oates MK; Amgen Inc., Thousand Oaks, California, USA., Recknor C; United Osteoporosis Centers, Gainesville, Georgia, USA., Libanati C; UCB Pharma, Brussels, Belgium.
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2021 Nov; Vol. 36 (11), pp. 2139-2152. Date of Electronic Publication: 2021 Aug 10.